Diagnosis and treatment of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal toxicity (Q33883996)

29 July 2017

1 reference

title

Diagnosis and treatment of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal toxicity (English)

1 reference

29 July 2017

Cappell MS

1

1 reference

PubMed ID

10752019

29 July 2017

Schein JR

series ordinal

2

1 reference

29 July 2017

1 March 2000

1 reference

Gastroenterology Clinics of North America

29 July 2017

1 reference

29 July 2017

29

1 reference

29 July 2017

1

1 reference

29 July 2017

97-124, vi

1 reference

Gastrointestinal bleeding: dyspeptic symptoms and clinical course in relation to use of non-steroidal antiinflammatory drugs

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

The relation between Helicobacter pylori and nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Improving management of duodenal ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Nonclinical model for assessing gastric effects of bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Nonsteroidal antiinflammatory drugs--differences and similarities

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Natural history, symptomatology, and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Esophagitis dissecans superficialis and alendronate: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Safety and efficacy of esophagogastroduodenoscopy after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

"Pill esophagitis"--the case of alendronate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Absence of abdominal pain in elderly patients with peptic ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Ranitidine, aspirin, food, and the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Non-steroidal anti-inflammatory drugs and peptic ulcer perforation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs and a general population referred for endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Esophagitis associated with the use of alendronate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Frequency of peptic ulcer among executives, craftsmen, and foreman

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Alendronate induces gastric injury and delays ulcer healing in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Histological features do not define NSAID-induced gastritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Long-term estrogen replacement therapy prevents bone loss and fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Colchicine enhances intestinal permeability in patients with familial Mediterranean fever

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Cigarettes, alcohol, coffee and peptic ulcer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

The successful medical management of gastric outflow obstruction associated with the use of non-steroidal anti-inflammatory drugs in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Prevention and treatment of osteoporosis: does the future belong to hormone replacement therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Mucosal biopsy of the esophagus, stomach, and proximal duodenum

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Management of NSAID-induced gastropathy: an economic decision analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Age-associated decreases in prostaglandin contents in human gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Aspirin and the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis. A review and suggestions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Future treatments for arthritis: new NSAIDs, NO NSAIDs, or no NSAIDs?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

The gastroenterologist's caseload: contribution of the rheumatologist

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

NSAIDs, Cox-2 inhibitors, and the gut

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Nonsteroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Prostaglandin E in peptic ulcer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Nonsteroidal anti-inflammatory drugs and the gut.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Gastrointestinal complications of nonsteroidal anti-inflammatory drugs: prophylactic and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Osteoporosis. Current pharmacologic options for prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

NSAIDS and the microcirculation of the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Incidence of gastrointestinal side effects due to alendronate is high in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Symptoms in gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Cephalosporin antibiotics accelerate gastric emptying in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Evidence of aspirin use in both upper and lower gastrointestinal perforation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Esophageal stricture associated with alendronate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

The hydrophobic barrier properties of gastrointestinal mucus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Treatment of postmenopausal osteoporosis with transdermal estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

1 reference

7 January 2021

Symptoms in patients with peptic ulcer and hematemesis and/or melena related to the use of non-steroid anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

From the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Prospective screening of dyspeptic patients by Helicobacter pylori serology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Current and potential future drug treatments for osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Building a better aspirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Mechanisms of gastroduodenal protection by sucralfate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Is senile dementia "age-related" or "ageing-related"?--evidence from meta-analysis of dementia prevalence in the oldest old

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Alendronate-induced esophagitis: case report of a recently recognized form of severe esophagitis with esophageal stricture--radiographic features.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Age-specific diagnostic values of the blood urea nitrogen/creatinine ratio in distinguishing upper from lower gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

NSAIDs, gastrointestinal injury, and cytoprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Drug interactions with warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Effect of non-steroidal anti-inflammatory drugs on dyspeptic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

The risks and costs of upper gastrointestinal disease attributable to NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

The eicosanoids and their biochemical mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Prevention of stricture formation after endoscopic sclerotherapy of esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Toxicity of nonsteroidal anti-inflammatory drugs in the elderly: is advanced age a risk factor?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Esophageal ulceration due to alendronate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

NSAID-induced gastroduodenal damage: is prevention needed? A review and metaanalysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Nature of the bleeding vessel in recurrently bleeding gastric ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Rising frequency of ulcer perforation in elderly people in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

Future trends in the development of safer nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970109-6

7 January 2021

10.1016/S0889-8553(05)70109-6

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10752019